Enlisting Deep Learning in the War on Cancer

By John Russell

December 7, 2016

Sometime in Q2 2017 the first ‘results’ of the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) will become publicly available according to Rick Stevens. He leads one of three JDACS4C pilot projects pressing deep learning (DL) into service in the War on Cancer. The pilots, supported in part by DOE exascale funding, not only seek to do good by advancing cancer research and therapy but also to advance deep learning capabilities and infrastructure with an eye towards eventual use on exascale machines.

By any standard, the U.S. War on Cancer and the Precision Medicine Initiative’s (PMI) are ambitious. Past Wars on Cancer haven’t necessarily fared well, which is not to say much hasn’t been accomplished. Today’s timing seems more promising. Progress in biomedical science and the ramp-up of next gen leadership computers (en route to exascale) are powerful enablers. Stir in the rapid emergence of deep learning to exploit data-driven science and many see greater cause for optimism. Not by chance was the opening plenary panel at SC16 on precision medicine and the role of HPC.

The three JDACS4C pilots span molecular to population scale efforts in support of the CANcer Distributed Learning Environment (CANDLE) project: they are intended to “provide insight into scalable machine learning tools; deep learning, simulation and analytics to reduce time to solution; and inform design of future computing solutions.” The hope is also to establish “a new paradigm for cancer research for years to come by making effective use of the ever-growing volumes and diversity of cancer-related data to build predictive models, provide better understanding of the disease and, ultimately, provide guidance and support decisions on anticipated outcomes of treatment for individual patients.”

Rick Stevens, ANL

These are ambitious goals. Sorting out JDACS4C’s precise lineage is a little challenging – it falls broadly under the Precision Medicine Initiative, NCI Cancer Moonshot, and has been also lumped under NSCI. Stevens noted the early discussion to create the effort started a couple of years ago with the first funding issued in the August time frame. Here’s a snapshot of the three pilots:

  • RAS Molecular Project. This project (Molecular Level Pilot for RAS Structure and Dynamics in Cellular Membranes) is intended to develop new computational approaches supporting research already being done under the RAS Initiative. Ultimately the hope is to refine our understanding of the role of the RAS (gene family) and its associated signaling pathway in cancer and to identify new therapeutic targets uniquely present in RAS protein membrane signaling complexes.
  • Pre-Clinical Screening. This project (Cellular Level Pilot for Predictive Modeling for Pre-clinical Screening) will develop “machine learning, large-scale data and predictive models based on experimental biological data derived from patient-derived xenografts.” The idea is to create a feedback loop, where the experimental models inform the design of the computational models. These predictive models may point to new targets in cancer and help identify new treatments.

Not surprisingly, there are many organizational pieces required. NCI components include the Center for Biomedical Informatics and Information Technology (CBIIT), the Division of Cancer Treatment and Diagnosis (DCTD), the Division of Cancer Control and Population Science (DCCPS), and the Frederick National Laboratory for Cancer Research. There are also four DOE National Laboratories formally designated on the project – Argonne National Laboratory, Oak Ridge National Laboratory, Lawrence Livermore National Laboratory, and Los Alamos National Laboratory.

As the projects came together, “We realized each had a need for deep learning and different uses of it. So the idea is that we would all work together on building both the software environment and network topologies and everything we would need for the three projects so we wouldn’t have duplication,” said Stevens. The researchers defined key benchmarks that “are tractable kinds of deep learning problems that are aligned with what we have to solve for the different cancer sub problems.”

An early first step was attracting vendor participation – something that turned out to be easy said Stevens because virtually all the major HPC vendors are aggressively ramping up DL roadmaps. Most see the JDACS4C pilots as opportunities to learn and refine. Stevens said JDASC4C has collaborations with Intel, Cray, NVIDIA, IBM, among others.

“All of the labs have DGX-1s and NVIDIA has optimized most of the common frameworks for the different GPUs, Pascal, etc. The DGX-1 is like an appliance so anything we build that runs on the DGX-1 can be easily distributed. Intel has it own extensive plans and not all is public yet. I can say that we are collaborating with all the right parts of Intel,” said Stevens, an ANL researcher and leader of the pre-clinical screening project.

Indeed Intel has been busy, buying Nervana (a complete platform for DL) and recently rolling out expanded plans. “They are talking about versions of Knights X series that are optimized for machine learning. Knights Mill is the first version of that part of their roadmap,” said Stevens. The chip giant also introduced a DL inference accelerator card at SC16; it’s a field-programmable gate array (FPGA)-based hardware and software solution for neural network acceleration. Stevens suggests Intel, like NVIDIA, is developing an appliance strategy.

“Intel is very much trying to define a strategy that differentiates some level between the platform for training and for inferencing. Most deep learning systems now do inferencing on the ‘quasi’ client side – on smaller platforms than used for training. Intel wants to ensure “future IA architectures are good at inferencing,” he said.

Not surprisingly  there’s a fair amount of effort assessing the many DL frameworks coming out of the Google, Microsoft, Facebook et al. “We are evaluating which frameworks work best for our problems and we are working with vendors to optimize them on the hardware. We’re also working with Livermore which has an internal project to build a scalable artificial neural network framework call LBANN,” said Stevens.

The plan is to develop “our models in a way that is independent of the frameworks so we can swap out the frameworks as those evolve without having to recode our models. This is a very common approach with deep learning where you have a scripting layer that captures your model representation – the meta algorithms for training and management data, etc. – and we are working with both the academic community and the NVIDIA on the workflow engine at the top. So we have kind of a stacked architecture and it involves collaborating with all of the different groups around the DL landscape.”

“What’s interesting,” said Stevens, “is the vendors for the next-gen platforms are strongly embracing the architectural ideas and features needed for accelerated machine learning in addition to traditional kind of physics-driven simulation.” He noted that market pressures and the fast growth of DL compared to the traditional HPC are pushing them in this direction. “It’s also giving us insight into DOE applications that are going to start looking like this – where there will be traditional physics-driven simulation, but where often we can find a way to leverage machine learning [too].”

Sharing the learning is an important component of the pilot projects. “We are abstracting model problems for the machine learning community to work on that are kind of sanitized versions of the seven candle benchmarks we’re working on,” said Stevens. That will include distributable data, code, all to be available at GitHub. The first of those elements are expected in Q2.

Individual pilot teams are also mounting their own outreach activities with the academic community. In terms of compute power for the pilots, “We are targeting platforms, particularly the CORAL platforms, new machines at Argonne, Oak Ridge and Livermore, and [eventually] exascale. Everything is sort of ecumenical so its not GPU specific or manycore specific.”

It’s interesting to look at the different ways in which the three projects plan to use deep learning.

The RAS project, at the molecular scale, is the smallest dimensional scale of all of the projects. RAS, you may know, is a well-known family of oncogenes that code for signaling proteins embedded in the cell membrane. These proteins control signaling pathways that extend into the cell and drive very many diverse cellular processes. RAS is currently implicated in about 30 percent of cancers including some of the toughest such as pancreatic cancer. The pilot project will combine simulation and wet lab screening data in an effort to elaborate the details of the RAS-related signaling cascades and hopefully identify key places to intervene and new drugs to use.

Even a relatively small tumor may have “thousands of mutations, both driver mutations and many passenger mutations,” said Stevens. These genetic miscues can alter the important details of signaling networks. For many years RAS itself as well as its associated signaling networks have been drug targets but as Stevens pointed out, “the behavior of that signaling network is very non-intuitive. Sometimes if you hit one of the downstream components, it actually creates negative feedback, which actually increases the effect you are trying to inhibit.”

In the RAS project, the simulation is basically a molecular dynamics exercise conducted at various granularities extending all the way down to atomistic behavior including quantum effects. The computational power required, not surprisingly, depends on the level of granularity being simulated and can be substantial.

“Machine learning is being used to track the state space that the simulation is going through and to make decisions – do we zoom in here, do we zoom out, do we change the parameters that we are looking in a different part to the ensemble space. It’s basically acting like a smart supervisor of this simulation to more effectively use it.

“In some sense it’s like the network is watching a movie and saying, “OK, I’ve seen this part of the movie before, let’s fast forward, or wow this is really interesting I’ve never seen this before, let’s use slow motion and zoom in.” That’s sort of what the machine learning is doing in the simulation. It’s able to fast forward and skip around in some sense,” said Stevens.

The pre-clinical screening project, led by Stevens, is an ambitious effort to sift through basically as much cancer  preclinical and clinical data as it can lay hold of and combine that with new data generated from mouse models to build predictive models of drug-tumor interactions. It’s an in silico and experimental feedback approach. Ultimately, given a specific tumor whose molecular attributes (gene expression, SNPs, proteomics, etc) have been characterized, it should be possible to plug that data into a model to determine the best therapeutic regime.

The subtlety here, said Stevens, is there has been a lot of machine learning work in this done at kind of the small scale, that is on single classes of tumors or relatively small classes of drugs. “What we are trying to do with the deep learning is to integrate all of this information across thousands of cell lines, tens of thousands of compounds that have been screened against smaller number of cell lines, and then be able to project that into a mouse. You grow a colony of mice derived from that human tumor, and these mice become proxies for human clinical trials. So I can try different compounds on the colony of tumor mice to provide information about how my tumor might respond to them if given as a drug.”

A huge challenge is being able to make sense of all the historical data, much of which is unstructured and often subjective (e.g. pathology reports). “One of the first things that we have done is to build classifiers to tell us what type the tumor is or where the body site is [based on diverse data],” he said. Not infrequently the data may be suspect. “If it’s a new dataset we run it through our classifiers and they may say, really, this is not from the liver, it’s from some other place.”

As a rule, the preclinical data is outcome based; it doesn’t explain how the result was achieved.

“Right now we can build machine learning models that are pretty accurate at say predicting a drug response or tumor type or outcome but they can’t tell us very effectively why. They are not explanatory, not mechanistic,” said Stevens, “What we want to do is bring in mechanistic models or mechanistic data in some way and hybridize that with machine learning models so that we get two things. We get the ability to have a highly accurate predictable model but also a model that can explain why that prediction. So the idea of this hybrid approach is a wide open space and we think that this will generalize into many fields.” Obtaining large and high quality data for training models remains challenging, he said.

The third project strives to develop models able to make population scale forecasts, what Stevens call “patient trajectories.” It’s basically mining surveillance data across the country. Although somewhat dispersed, there is a great deal of patient data held by NCI, NIH, FDA, pharma, and payor organizations (pathology reports, treatments, outcomes, lifestyle, demographics, etc.). Unfortunately, like a lot of biomedical data, it’s largely unstructured. “We can’t really compute on it in the way we want to so we are using machine learning to translate the unstructured data into structured data we can compute on,” said Stevens

“So for example we want to read all the pathology reports with a machine and pull out, say the biomarkers, the mutational state, or the drugs and so on such that we can then build profiles that are consistent. Think of it as a population-based model. In preclinical screening pilot let’s say we uncover some treatments and strategies that are very effective on a certain type of cancer. We want to take that information and feed it into the population model and say “If this became a common therapy, how much would it change the statistics globally or nationally” or something like that.”

It’s also a way to link all of the pilots, said Steven. Insight from the RAS project might be later used to look at subclasses of cancers where the new treatment might work; that in turn put it into the population model to understand what the impact of that might be.

It’s still early days for the JDACS4C pilot projects, but hopes are high. Stevens noted both NCI and DOE are getting access to things they don’t readily have. “NCI does not have a lot of mathematicians and computer scientists, which DOE has. They also don’t have access to leadership machines. What we (DOE) are getting is access to all of this great experimental data, experimental facilities, public databases.”

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

The Case for an Edge-Driven Future for Supercomputing

September 24, 2021

“Exascale only becomes valuable when it’s creating and using data that we care about,” said Pete Beckman, co-director of the Northwestern-Argonne Institute of Science and Engineering (NAISE), at the most recent HPC Read more…

Three Universities Team for NSF-Funded ‘ACES’ Reconfigurable Supercomputer Prototype

September 23, 2021

As Moore’s law slows, HPC developers are increasingly looking for speed gains in specialized code and specialized hardware – but this specialization, in turn, can make testing and deploying code trickier than ever. Now, researchers from Texas A&M University, the University of Illinois at Urbana... Read more…

Qubit Stream: Monte Carlo Advance, Infosys Joins the Fray, D-Wave Meeting Plans, and More

September 23, 2021

It seems the stream of quantum computing reports never ceases. This week – IonQ and Goldman Sachs tackle Monte Carlo on quantum hardware, Cambridge Quantum pushes chemistry calculations forward, D-Wave prepares for its Read more…

Asetek Announces It Is Exiting HPC to Protect Future Profitability

September 22, 2021

Liquid cooling specialist Asetek, well-known in HPC circles for its direct-to-chip cooling technology that is inside some of the fastest supercomputers in the world, announced today that it is exiting the HPC space amid multiple supply chain issues related to the pandemic. Although pandemic supply chain... Read more…

TACC Supercomputer Delves Into Protein Interactions

September 22, 2021

Adenosine triphosphate (ATP) is a compound used to funnel energy from mitochondria to other parts of the cell, enabling energy-driven functions like muscle contractions. For ATP to flow, though, the interaction between the hexokinase-II (HKII) enzyme and the proteins found in a specific channel on the mitochondria’s outer membrane. Now, simulations conducted on supercomputers at the Texas Advanced Computing Center (TACC) have simulated... Read more…

AWS Solution Channel

Introducing AWS ParallelCluster 3

Running HPC workloads, like computational fluid dynamics (CFD), molecular dynamics, or weather forecasting typically involves a lot of moving parts. You need a hundreds or thousands of compute cores, a job scheduler for keeping them fed, a shared file system that’s tuned for throughput or IOPS (or both), loads of libraries, a fast network, and a head node to make sense of all this. Read more…

The Latest MLPerf Inference Results: Nvidia GPUs Hold Sway but Here Come CPUs and Intel

September 22, 2021

The latest round of MLPerf inference benchmark (v 1.1) results was released today and Nvidia again dominated, sweeping the top spots in the closed (apples-to-apples) datacenter and edge categories. Perhaps more interesti Read more…

The Case for an Edge-Driven Future for Supercomputing

September 24, 2021

“Exascale only becomes valuable when it’s creating and using data that we care about,” said Pete Beckman, co-director of the Northwestern-Argonne Institut Read more…

Three Universities Team for NSF-Funded ‘ACES’ Reconfigurable Supercomputer Prototype

September 23, 2021

As Moore’s law slows, HPC developers are increasingly looking for speed gains in specialized code and specialized hardware – but this specialization, in turn, can make testing and deploying code trickier than ever. Now, researchers from Texas A&M University, the University of Illinois at Urbana... Read more…

Qubit Stream: Monte Carlo Advance, Infosys Joins the Fray, D-Wave Meeting Plans, and More

September 23, 2021

It seems the stream of quantum computing reports never ceases. This week – IonQ and Goldman Sachs tackle Monte Carlo on quantum hardware, Cambridge Quantum pu Read more…

Asetek Announces It Is Exiting HPC to Protect Future Profitability

September 22, 2021

Liquid cooling specialist Asetek, well-known in HPC circles for its direct-to-chip cooling technology that is inside some of the fastest supercomputers in the world, announced today that it is exiting the HPC space amid multiple supply chain issues related to the pandemic. Although pandemic supply chain... Read more…

TACC Supercomputer Delves Into Protein Interactions

September 22, 2021

Adenosine triphosphate (ATP) is a compound used to funnel energy from mitochondria to other parts of the cell, enabling energy-driven functions like muscle contractions. For ATP to flow, though, the interaction between the hexokinase-II (HKII) enzyme and the proteins found in a specific channel on the mitochondria’s outer membrane. Now, simulations conducted on supercomputers at the Texas Advanced Computing Center (TACC) have simulated... Read more…

The Latest MLPerf Inference Results: Nvidia GPUs Hold Sway but Here Come CPUs and Intel

September 22, 2021

The latest round of MLPerf inference benchmark (v 1.1) results was released today and Nvidia again dominated, sweeping the top spots in the closed (apples-to-ap Read more…

Why HPC Storage Matters More Now Than Ever: Analyst Q&A

September 17, 2021

With soaring data volumes and insatiable computing driving nearly every facet of economic, social and scientific progress, data storage is seizing the spotlight. Hyperion Research analyst and noted storage expert Mark Nossokoff looks at key storage trends in the context of the evolving HPC (and AI) landscape... Read more…

GigaIO Gets $14.7M in Series B Funding to Expand Its Composable Fabric Technology to Customers

September 16, 2021

Just before the COVID-19 pandemic began in March 2020, GigaIO introduced its Universal Composable Fabric technology, which allows enterprises to bring together Read more…

Ahead of ‘Dojo,’ Tesla Reveals Its Massive Precursor Supercomputer

June 22, 2021

In spring 2019, Tesla made cryptic reference to a project called Dojo, a “super-powerful training computer” for video data processing. Then, in summer 2020, Tesla CEO Elon Musk tweeted: “Tesla is developing a [neural network] training computer called Dojo to process truly vast amounts of video data. It’s a beast! … A truly useful exaflop at de facto FP32.” Read more…

Enter Dojo: Tesla Reveals Design for Modular Supercomputer & D1 Chip

August 20, 2021

Two months ago, Tesla revealed a massive GPU cluster that it said was “roughly the number five supercomputer in the world,” and which was just a precursor to Tesla’s real supercomputing moonshot: the long-rumored, little-detailed Dojo system. “We’ve been scaling our neural network training compute dramatically over the last few years,” said Milan Kovac, Tesla’s director of autopilot engineering. Read more…

Esperanto, Silicon in Hand, Champions the Efficiency of Its 1,092-Core RISC-V Chip

August 27, 2021

Esperanto Technologies made waves last December when it announced ET-SoC-1, a new RISC-V-based chip aimed at machine learning that packed nearly 1,100 cores onto a package small enough to fit six times over on a single PCIe card. Now, Esperanto is back, silicon in-hand and taking aim... Read more…

CentOS Replacement Rocky Linux Is Now in GA and Under Independent Control

June 21, 2021

The Rocky Enterprise Software Foundation (RESF) is announcing the general availability of Rocky Linux, release 8.4, designed as a drop-in replacement for the soon-to-be discontinued CentOS. The GA release is launching six-and-a-half months after Red Hat deprecated its support for the widely popular, free CentOS server operating system. The Rocky Linux development effort... Read more…

Intel Completes LLVM Adoption; Will End Updates to Classic C/C++ Compilers in Future

August 10, 2021

Intel reported in a blog this week that its adoption of the open source LLVM architecture for Intel’s C/C++ compiler is complete. The transition is part of In Read more…

Hot Chips: Here Come the DPUs and IPUs from Arm, Nvidia and Intel

August 25, 2021

The emergence of data processing units (DPU) and infrastructure processing units (IPU) as potentially important pieces in cloud and datacenter architectures was Read more…

AMD-Xilinx Deal Gains UK, EU Approvals — China’s Decision Still Pending

July 1, 2021

AMD’s planned acquisition of FPGA maker Xilinx is now in the hands of Chinese regulators after needed antitrust approvals for the $35 billion deal were receiv Read more…

Google Launches TPU v4 AI Chips

May 20, 2021

Google CEO Sundar Pichai spoke for only one minute and 42 seconds about the company’s latest TPU v4 Tensor Processing Units during his keynote at the Google I Read more…

Leading Solution Providers

Contributors

10nm, 7nm, 5nm…. Should the Chip Nanometer Metric Be Replaced?

June 1, 2020

The biggest cool factor in server chips is the nanometer. AMD beating Intel to a CPU built on a 7nm process node* – with 5nm and 3nm on the way – has been i Read more…

HPE Wins $2B GreenLake HPC-as-a-Service Deal with NSA

September 1, 2021

In the heated, oft-contentious, government IT space, HPE has won a massive $2 billion contract to provide HPC and AI services to the United States’ National Security Agency (NSA). Following on the heels of the now-canceled $10 billion JEDI contract (reissued as JWCC) and a $10 billion... Read more…

Julia Update: Adoption Keeps Climbing; Is It a Python Challenger?

January 13, 2021

The rapid adoption of Julia, the open source, high level programing language with roots at MIT, shows no sign of slowing according to data from Julialang.org. I Read more…

Quantum Roundup: IBM, Rigetti, Phasecraft, Oxford QC, China, and More

July 13, 2021

IBM yesterday announced a proof for a quantum ML algorithm. A week ago, it unveiled a new topology for its quantum processors. Last Friday, the Technical Univer Read more…

Intel Launches 10nm ‘Ice Lake’ Datacenter CPU with Up to 40 Cores

April 6, 2021

The wait is over. Today Intel officially launched its 10nm datacenter CPU, the third-generation Intel Xeon Scalable processor, codenamed Ice Lake. With up to 40 Read more…

Frontier to Meet 20MW Exascale Power Target Set by DARPA in 2008

July 14, 2021

After more than a decade of planning, the United States’ first exascale computer, Frontier, is set to arrive at Oak Ridge National Laboratory (ORNL) later this year. Crossing this “1,000x” horizon required overcoming four major challenges: power demand, reliability, extreme parallelism and data movement. Read more…

Intel Unveils New Node Names; Sapphire Rapids Is Now an ‘Intel 7’ CPU

July 27, 2021

What's a preeminent chip company to do when its process node technology lags the competition by (roughly) one generation, but outmoded naming conventions make it seem like it's two nodes behind? For Intel, the response was to change how it refers to its nodes with the aim of better reflecting its positioning within the leadership semiconductor manufacturing space. Intel revealed its new node nomenclature, and... Read more…

Top500: Fugaku Still on Top; Perlmutter Debuts at #5

June 28, 2021

The 57th Top500, revealed today from the ISC 2021 digital event, showcases many of the same systems as the previous edition, with Fugaku holding its significant lead and only one new entrant in the top 10 cohort: the Perlmutter system at the DOE Lawrence Berkeley National Laboratory enters the list at number five with 65.69 Linpack petaflops. Perlmutter is the largest... Read more…

  • arrow
  • Click Here for More Headlines
  • arrow
HPCwire